Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
| Price | 621.00p on 09-01-2026 at 19:40:07 |
|---|---|
| Change | -3.00p -0.48% |
| Buy | 642.00p |
| Sell | 600.00p |
| Last Trade: | Sell 207.00 at 611.34p |
| Day's Volume: | 13,466 |
| Last Close: | 621.00p |
| Open: | 624.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 124.50p - 1,790.00p |
| Market Capitalisation: | £37.70m |
| VWAP: | 621.92738p |
| Shares in Issue: | 6.04m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 207 | 611.34p | Ordinary |
16:23:46 - 09-Jan-26 |
| Sell* | 492 | 611.361p | Ordinary |
16:18:38 - 09-Jan-26 |
| Buy* | 1,090 | 630.00p | Ordinary |
15:38:13 - 09-Jan-26 |
| Unknown* | 0 | 592.00p | SI Trade |
15:22:19 - 09-Jan-26 |
| Buy* | 32 | 642.00p | SI Trade |
15:22:19 - 09-Jan-26 |
| Buy* | 39 | 625.49p | Ordinary |
15:22:01 - 09-Jan-26 |
| Buy* | 143 | 625.49p | Ordinary |
14:27:42 - 09-Jan-26 |
| Unknown* | 38 | 592.00p | OTC Trade |
13:17:14 - 09-Jan-26 |
| Unknown* | 2,500 | 625.00p | Ordinary |
12:59:37 - 09-Jan-26 |
| Unknown* | 14 | 638.00p | OTC Trade |
12:39:16 - 09-Jan-26 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Dec 2025 8:00 am | RNS | Update on Admission of Shares |
| 18th Dec 2025 7:00 am | RNS | Issue of Equity |
| 8th Dec 2025 12:48 pm | RNS | Holding(s) in Company |
| 28th Nov 2025 7:00 am | RNS | Total Voting Rights |
| 19th Nov 2025 11:47 am | RNS | Publication of Prospectus |
| 29th Oct 2025 7:00 am | RNS | Clinical Trial Update and Grant of Share Awards |
| 6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 30th Sep 2025 7:00 am | RNS | Total Voting Rights |
| 23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |